Hepatitis C virus (HCV) E1 and E2 protein regions that specifically bind to HepG2 cells

Journal of Hepatology

Volumn 36, Issue 2, 2002, Pages 254-262

  Garcia, Javier Eduardo ^a   Puentes, Alvaro ^a   Suárez, Jorge ^a   López, Ramses ^a   Vera, Ricardo ^a   Rodríguez, Luis Eduardo ^a   Ocampo, Marisol ^a   Curtidor, Hernando ^a   Guzmán, Fanny ^a   Urquiza, Mauricio ^a   Patarroyo, Manuel Elkin ^a  

^a UNIVERSIDAD NACIONAL DE COLOMBIA   (Colombia)

Author keywords

Envelope proteins; Hepatitis C virus; HepG2 binding; Hypervariable region 1

Indexed keywords

BINDING PROTEIN; CD81 ANTIGEN; CELL SURFACE PROTEIN; PEPTIDE; VIRUS ENVELOPE PROTEIN; VIRUS PROTEIN;

ANTIGENICITY; ARTICLE; BINDING AFFINITY; BINDING SITE; CELL MEMBRANE; CONTROLLED STUDY; CROSS LINKING; GEL ELECTROPHORESIS; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; IMMUNOGENICITY; LIVER CELL; PRIORITY JOURNAL; PROTEIN BINDING; RAJI CELL; SEQUENCE ANALYSIS;

AMINO ACID SEQUENCE; GENOTYPE; HEPACIVIRUS; HEPATITIS C; HUMANS; IODINE RADIOISOTOPES; LIVER NEOPLASMS; MOLECULAR SEQUENCE DATA; PROTEIN BINDING; TUMOR CELLS, CULTURED; VIRAL ENVELOPE PROTEINS; VIRAL PROTEINS;

EID: 0036172312     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(01)00262-8     Document Type: Article

References (44)

1. Isolation of a cDNA clone derived from a blood born Non-A, Non-B viral hepatitis genome
2. Genetic organization and diversity of the hepatitis C virus
3. Molecular cloning of the human hepatitis C virus genome from Japanese patients with non-A, non-B hepatitis
4. Biosynthesis and bichemical properties of the hepatitis C virus core protein
5. Expression and identification of hepatitis C virus polyprotein cleavage products
6. Gene mapping of the putative structural region of the hepatitis C virus genome by in vitro processing analysis
7. Processing in the hepatitis C virus E2-NS2 region: Identification of p7 and two distinct E2-specific products with different C termini
8. A quantitative test to estimate neutralizing antibodies to the hepatitis C virus: Cytofluorimetric assessment of envelope glycoprotein 2 binding to target cells
9. Structure-function analysis of hepatitis C virus envelope-CD81 binding
10. Binding of hepatitis C virus to CD81
11. Identification of amino acid residues in CD81 critical for interaction with hepatitis C virus envelope glycoprotein E2
12. Characterization of hepatitis C virus E2 glycoprotein interaction with a putative cellular receptor, CD81
13. Vaccination of chimpanzees against infection by the hepatitis C virus
14. Experimental vaccine activities of recombinant E1 and E2 glycoproteins and hypervariable region 1 peptides of hepatitis C virus in chimpanzees
15. Monoclonal antibodies to the hyper-variable region a1 of hepatitis C virus capture virus and inhibit virus adsorption to susceptible cells in vitro
16. Characterization of antibody response to hepatitis C virus protein E2 and significance of hypervariable region ! -specific antibodies in viral neutralization
17. Antibodies in human sera specific to hypervariable region 1 of hepatitis C virus can block viral attachment
18. Genetic drift in hypervariable region 1 of the viral genome in persistent hepatitis C virus infection
19. Genetic alterations of the putative envelope proteins encoding region of the hepatitis C virus in the progression to relapsed phase from acute hepatitis: Humoral immune response to hypervariable region 1
20. Identification of a domain containing B-Cell epitopes in hepatitis C virus E2 glycoprotein by using mouse monoclonal antibodies
21. Characterization and mapping of a B-cell immunogenic domain in hepatitis C virus E2 glycoprotein using a yeast peptide library
22. Controlled synthesis of HBsAg in a differentiated human liver carcinoma-derived cell line
23. In vitro infection of human hepatoma (HepG2) cell with hepatitis B virus
24. Solid phase peptide synthesis I. The synthesis of a tetrapeptide
25. Identification of peptides from the Plasmodium falciparum MSP-1 protein able to bind to red blood cells
26. Amino terminal peptides of the ring infected erythrocyte surface antigen of Plasmodium falciparum bind specifically to erythrocytes
27. Identification and chemical synthesis of a host cell receptor binding site on hepatitis B virus
28. Plasmodium falciparum EBA-175 kDa protein peptide which bind to human red blood cells
29. Isolation of rat heaptocyte plasma membranes
30. Serine repeat antigens peptides bind specifically to red blood cells
31. Sequence analysis of the core gene of 14 hepatitis C virus genotypes
32. Transcripts from a single full-length cDNA clone of hepatitis C virus are infectious when directly transfected into the liver of chimpanzee
33. Hepatitis C virus: An infectious molecular clone of a second major genotype (2a) and lack of viability of intertypic 1a and 2a chimeras
34. Assessment of hepatitis C virus sequence complexity by electrophoretic mobilities of both single- and double-stranded DNAs
35. Prevalence of hepatitis C virus sequence variants in South-East Asia
36. Transmission of hepatitis C by intrahepatic inoculation with transcribed RNA
37. Detection of a cluster of hepatitis C infections in a renal transplant unit by analysis of sequence variation of the NS% a gene
38. At least 12 genotypes of hepatitis C virus predicted by sequence analysis of the putative E1 gene of isolates collected worldwide
39. Prevention of hepatitis C virus infection in chimpanzees by hyperimmune serum against the hypervariable region 1 of the envelope 2 protein
40. Neutralizing antibodies against hepatitis C virus and the emergence of neutralization escape mutant viruses
41. Detection of antibodies to hepatitis C virus (HCV) structural proteins in anti-HCV-positive sera by an enzyme-linked immunosorbent assay using synthetic peptides as antigens
42. A hyperimmune serum against a synthetic peptide corresponding to the hypervariable region 1 of hepatitis C virus can prevent viral infection in cell cultures